A Study of LY3502970 in Healthy Overweight and Obese Participants

Part of paid clinical trials in Miami, Florida.

Sponsor
Eli Lilly and Company
Study ID
NCT05313802
Phase
PHASE1
Status
Completed

Conditions

  • Healthy
  • Obese

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • LY3502970 — DRUG
    Administered orally.

Study Details

The main purpose of this study is to evaluate the safety and tolerability of LY3502970 in healthy overweight and obese participants. The blood tests will be conducted to measure how much LY3502970 is in the bloodstream and how the body handles and eliminates LY3502970 in these participants. The study will last up to 42 days excluding the screening period.

Key Dates

Start date
May 26, 2022
Status verified
Apr 2026
Primary completion
Sep 9, 2022
Completion
Sep 9, 2022

Study Design

Enrollment
72 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: LY3502970 Cohort 1
    Participants received oral doses of 2 milligrams (mg) LY3502970 from days 1-14 and 3 mg LY3502970 from days 15-28 once daily (QD).
  • Experimental: LY3502970 Cohort 2
    Participants received oral doses of 1 mg LY3502970 from days 1-7, 2 mg LY3502970 from days 8-21 and 3 mg LY3502970 from days 22-28 QD.
  • Experimental: LY3502970 Cohort 3
    Participants received oral doses of 1 mg LY3502970 from days 1-14, 2 mg LY3502970 from days 15-21 and 3 mg LY3502970 from days 22-28 QD.

Primary Outcome Measure

Number of Participants With One or More Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration [ Time Frame: Baseline up to Day 42 ]

Locations (3)

FacilityCityStateZIPSite coordinators
Qps-Mra, LlcMiamiFlorida33143-
ICON Early Phase Services Lenexa CenterLenexaKansas66219-
ICON Early Phase ServicesSan AntonioTexas78209-

Related coverage on Hipa.ai

Find similar trials in Miami, FL

By research site
Qps-Mra, Llc· Miami, FLICON Early Phase Services Lenexa Center· Lenexa, KSICON Early Phase Services· San Antonio, TX

Related Studies